Fingerprint
Dive into the research topics where Burcu Aslan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer (eBioMedicine (2018) 38 (100–112), (S2352396418304973), (10.1016/j.ebiom.2018.11.004))
Kanlikilicer, P., Bayraktar, R., Denizli, M., Rashed, M. H., Ivan, C., Aslan, B., Mitra, R., Karagoz, K., Bayraktar, E., Zhang, X., Rodriguez-Aguayo, C., El-Arabey, A. A., Kahraman, N., Baydogan, S., Ozkayar, O., Gatza, M. L., Ozpolat, B., Calin, G. A., Sood, A. K. & Lopez-Berestein, G., Jan 2025, In: EBioMedicine. 111, 105486.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression
Tantawy, S. I., Aslan, B., Manyam, G., Iles, L. K. R., Timofeeva, N., Singh, N., Jain, N., Ferrajoli, A., Thompson, P. A., Patel, K. P., Desikan, S. P., Wierda, W. G. & Gandhi, V., Dec 2025, In: Blood cancer journal. 15, 1, 183.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib
Aslan, B., Manyam, G., Iles, L. R., Tantawy, S. I., Desikan, S. P., Wierda, W. G. & Gandhi, V., Sep 10 2024, In: Blood Advances. 8, 17, p. 4487-4501 15 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Curing CLL: one clone at a time
Aslan, B., Tantawy, S. I. & Gandhi, V., May 9 2023, In: Blood Advances. 7, 9, p. 1926-1928 3 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
CLL-532 Changes in Proteome of CLL (Chronic Lymphocytic Leukemia) Lymphocytes During Investigator-Initiated Trial of Ibrutinib Alone and in Combination With Venetoclax in Treatment-Naïve Patients With CLL
Timofeeva, N., Jain, N., Irajizad, E., Aslan, B., Katayama, H., Cai, Y., Ayres, M., Iles, L., Vykoukal, J., Dennison, J., Hanash, S., Wierda, W. & Gandhi, V., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S283Research output: Contribution to journal › Article › peer-review